Oaktree Specialty Lending Corp
XBER:FFC

Watchlist Manager
Oaktree Specialty Lending Corp Logo
Oaktree Specialty Lending Corp
XBER:FFC
Watchlist
Price: 10.79 EUR
Market Cap: €2B

Oaktree Specialty Lending Corp
Investor Relations

Oaktree Specialty Lending Corporation operates in the nuanced world of finance, where nimble strategies and prudent management are paramount. Based in Los Angeles, it is a part of the Oaktree Capital Management family, which has a reputation for its disciplined investment approach. The company specializes in providing customized debt and equity financing solutions to middle-market companies across a diverse array of industries. This focus allows it to fill a crucial gap in financing that many traditional banks may overlook. By leveraging its expertise and insight, Oaktree Specialty Lending aids these businesses during pivotal growth periods, often undertaking due diligence to ensure investments are aligned with its risk management and return standards.

The financial success of Oaktree Specialty Lending comes predominantly from the interest and fees garnered from these financing activities. Its strategic approach focuses on protecting capital and generating attractive returns by carefully crafting a balance between risk and reward. By investing in senior secured loans, it works to ensure first-lien security on the borrower's assets, which provides a safety net in case of defaults. This methodical and cautious strategy is underscored by a commitment to understanding the businesses they partner with, from evaluating financial health to understanding market dynamics. The company's model remains agile, adapting investment strategies in response to market fluctuations, ensuring it navigates the volatile seas of middle-market lending with aplomb.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Nov 18, 2025
AI Summary
Q4 2025

Net Investment Income: Adjusted net investment income rose to $0.40 per share, up from $0.37 last quarter, driven by higher prepayment fees, dividend income, and lower interest expense.

Dividend: The Board declared a quarterly dividend of $0.40 per share, consistent with earnings and policy.

Nonaccruals: Nonaccruals declined to 2.8% of the portfolio, improving both sequentially and year-on-year.

Portfolio Activity: New investment commitments grew 54% quarter-over-quarter, with a focus on senior secured loans and portfolio diversification.

NAV Decline: NAV per share decreased to $16.64 from $16.76, mainly due to unrealized depreciation.

Liquidity and Leverage: Liquidity remains strong at $695 million, with leverage at 0.97x—still at the lower end of the target range.

Market Outlook: Management remains cautious but optimistic about private credit, seeing steady deal flow despite mixed quality and tighter spreads.

Key Financials
Adjusted Net Investment Income
$35.4 million ($0.40 per share)
NAV per Share
$16.64
Adjusted Total Investment Income
$76.9 million
Weighted Average Cost of Borrowings
6.5%
Leverage Ratio
0.97x
Total Debt Outstanding
$1.5 billion
Liquidity
$695 million
Unfunded Commitments
$258.9 million
Nonaccruals (as % of portfolio fair value)
2.8%
Dividend
$0.40 per share
First Lien Loans (as % of new originations)
88%
Weighted Average Yield on Debt Investments
9.8%
JV Investments
$513 million
JV Aggregate ROE
12.4%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Armen Panossian J.D.
CEO & Chief Investment Officer
No Bio Available
Mr. Mathew M. Pendo
President
No Bio Available
Dr. Aman Kumar M.D.
Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
No Bio Available
Mr. Raghav Khanna
Managing Director & Co-Portfolio Manager
No Bio Available
Mr. Christopher McKown
MD,CFO & Treasurer
No Bio Available
Mr. Michael Mosticchio
Investor Relations
No Bio Available
Ms. Mary Gallegly J.D.
MD,General Counsel & Secretary
No Bio Available
Ms. Ashley Pak
Chief Compliance Officer
No Bio Available
Mr. Sandeep Kumar Khorana
Managing Director of Origination
No Bio Available
Ms. Lucia S. Kim
Senior Vice President
No Bio Available

Contacts

Address
CALIFORNIA
Los Angeles
333 S Grand Ave Fl 28
Contacts